Zorica Milošević

Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma

Zorica Milošević, Milica Pešić, Tijana Stanković et al. · Translational research · 2014 · 55 citations

Anaplastic Thyroid Carcinoma, Signaling Pathway, Medicine +7

Lactate dehydrogenase, Catalase, and Superoxide dismutase in Tumor Tissue of Breast Cancer Patients in Respect to Mammographic Findings

Sandra Radenković, Zorica Milošević, Gordana Konjević et al. · Cell Biochemistry and Biophysics · 2012 · 52 citations

Breast Oncology, Oncology, Biochemistry +12

Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma

Miodrag Dragoj, Zorica Milošević, Jasna Banković et al. · Cellular Oncology · 2016 · 43 citations

Doxorubicin Resistance, Medicine, Pathology +9

The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: The unique way of multi-drug resistance modulation

Jasna Banković, Jörg Andrä, Nataša V. Todorović et al. · Experimental Cell Research · 2013 · 36 citations

Multi-drug Resistance Modulation, Medicine, Immunology +8

Genomic instability and p53 alterations in patients with malignant glioma

Vedrana Milinković, Jasna Banković, Miodrag Rakić et al. · Experimental and Molecular Pathology · 2012 · 27 citations

Genome Instability, P53 Alterations, Glioma +7